INMB - INmune Bio Inc
IEX Last Trade
6.6
-0.260 -3.939%
Share volume: 110,251
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$6.86
-0.26
-3.79%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-11-02 | 2023-03-02 | 2023-05-03 | 2023-08-07 | 2023-11-01 | 2024-03-28 | 2024-05-09 | 2024-08-01 | |
Cash flow financing | 0.000 | 0.000 | 0.000 | 0.000 | -1.725 M | -2.500 M | -2.500 M | 12.997 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash flow | -3.367 M | -5.695 M | -1.141 M | -3.174 M | -4.264 M | -3.401 M | -7.476 M | -7.886 M | |
Net income | -7.725 M | -5.833 M | -6.536 M | -6.501 M | -8.563 M | -8.408 M | -11.025 M | -9.746 M | |
Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 4.531 M | 8.461 M | 2.210 M | 2.046 M | 2.263 M | 2.442 M | 2.690 M | 3.413 M | |
Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net Borrowings | -46.747 M | -40.904 M | -39.303 M | -35.176 M | -30.436 M | -27.063 M | -19.194 M | -26.651 M | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Cash Change | 57.405 M | 52.153 M | 51.003 M | 47.825 M | 41.813 M | 35.848 M | 26.002 M | 31.069 M |